Befejeződött1/2. fázis
Multicentric randomized phase I/IIa trial of the safety and immunogenicity of a therapeutic HPV DC targeting vaccine in patients with Human papillomavirus (HPV)-positive oropharyngeal cancer (HPV.DCVax)
Key facts
- Where
- Paris és Villejuif, FranciaországSee the 2 sites
- Phase
- 1/2. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Franciaország
- Institut CurieParis, FranciaországNo longer taking part
- Institut Gustave RoussyVillejuif, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Gustave Roussy
- Trial code
- EU 2022-502930-25-00
- Record updated
- 2025. október 8.